Sernova Corp.’s Stock Is Sell After Today’s Huge Decline


The stock of Sernova Corp. (CVE:SVA) is a huge mover today! The stock decreased 5.00% or $0.015 on September 13, hitting $0.285. About 91,250 shares traded hands or 9.33% up from the average. Sernova Corp. (CVE:SVA) has risen 6.00% since August 14, 2016 and is uptrending. It has underperformed by 10.49% the S&P500.
The move comes after 6 months negative chart setup for the $45.61M company. It was reported on Sep, 13 by We have $0.25 PT which if reached, will make CVE:SVA worth $5.02 million less.

Sernova Corp. is a regenerative medicine firm engaged in the research and development of its Cell Pouch and associated technologies, including therapeutic cells. The company has a market cap of $45.61 million. The Firm is focused on developing a treatment for insulin-dependent human diabetes and other metabolic, blood and neurological diseases with therapeutic cells placed into its implanted and prevascularized medical device and protected from immune system attack. It currently has negative earnings. The Cell Pouch is designed to create a microvessel rich, tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and/or hormones for the long-term treatment of serious, chronic diseases, such as diabetes, hemophilia and thyroid disease.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Reply